Please use this identifier to cite or link to this item:
|Title:||Paraprotein associated heparin resistance during cardiopulmonary bypass||Authors:||Khuong, Jacqueline N;Forsyth, Cecily J ;Manuel, Lucy;Kingsford-Smith, Kate;Srivastava, Arpit;Bassin, Levi||Affliation:||Central Coast Local Health District
|Issue Date:||14-Jun-2022||Source:||Online ahead of print||Journal title:||Perfusion||Department:||Haematology||Abstract:||Heparin resistance during cardiopulmonary bypass poses a significant intraoperative dilemma. Antithrombin deficiency related heparin resistance is well described, but less common causes are still poorly understood and inadequately managed. We present a case of heparin resistance during cardiopulmonary bypass in a gentleman with no previous haematological history or thrombotic risk factors. The patient required three times the regular dose of unfractionated heparin to achieve acceptable conditions to initiate and maintain bypass. The patient was found to have elevated serum immunoglobulin M (IgM) kappa paraprotein on post-operative investigation. Paraproteins may exhibit non-specific binding to long polymeric chains of unfractionated heparin and inhibits the interaction between heparin and antithrombin. As a result, excessive doses of heparin are required to overcome this, which increases the risk of perioperative bleeding and other complications. Elevated serum paraprotein levels should be recognised as a cause of heparin resistance during cardiopulmonary bypass.||URI:||https://elibrary.cclhd.health.nsw.gov.au/cclhdjspui/handle/1/2244||DOI:||10.1177/02676591221109143||Pubmed:||https://pubmed.ncbi.nlm.nih.gov/35700111/||Publicaton type:||Journal Article||Keywords:||Cardiology
|Study or Trial:||Case Series and Case Reports|
|Appears in Collections:||Haematology|
Show full item record
checked on Feb 3, 2023
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.